Welcome to LookChem.com Sign In|Join Free
  • or
2-Pyridin-3-yl-quinoline-4-carboxylic acid is a heterocyclic aromatic compound derived from both pyridine and quinoline. It features a quinoline ring attached to a pyridine ring by a single bond, with a carboxylic acid group at the 4-position of the quinoline ring. 2-PYRIDIN-3-YL-QUINOLINE-4-CARBOXYLIC ACID is characterized by its extensive conjugation, aromaticity, and the presence of a polar carboxylic acid group capable of hydrogen bonding, which can influence its properties. Although its applications are not widely reported, it is primarily used for research purposes.

7482-91-9

Post Buying Request

7482-91-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7482-91-9 Usage

Uses

Used in Research Applications:
2-Pyridin-3-yl-quinoline-4-carboxylic acid is used as a research compound for exploring its chemical properties, potential interactions, and possible applications in various fields. Its unique molecular structure and the presence of aromatic rings and a carboxylic acid group make it an interesting subject for scientific investigation.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-Pyridin-3-yl-quinoline-4-carboxylic acid is used as a starting material or intermediate in the synthesis of various drug candidates. Its aromatic and polar characteristics may contribute to the development of new therapeutic agents with specific biological activities.
Used in Chemical Synthesis:
2-Pyridin-3-yl-quinoline-4-carboxylic acid is used as a building block in the synthesis of complex organic compounds and materials. Its versatile structure allows for further functionalization and modification, enabling the creation of new molecules with tailored properties for various applications.
Used in Material Science:
In the field of material science, 2-Pyridin-3-yl-quinoline-4-carboxylic acid may be utilized in the development of novel materials with specific optical, electronic, or magnetic properties. Its aromatic and conjugated nature could contribute to the design of advanced materials for various technological applications.

Check Digit Verification of cas no

The CAS Registry Mumber 7482-91-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,4,8 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 7482-91:
(6*7)+(5*4)+(4*8)+(3*2)+(2*9)+(1*1)=119
119 % 10 = 9
So 7482-91-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H10N2O2/c18-15(19)12-8-14(10-4-3-7-16-9-10)17-13-6-2-1-5-11(12)13/h1-9H,(H,18,19)

7482-91-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-pyridin-3-ylquinoline-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2-[3]Pyridyl-chinolin-4-carbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7482-91-9 SDS

7482-91-9Downstream Products

7482-91-9Relevant academic research and scientific papers

Design of a dual sensing highly selective cyanide chemodosimeter based on pyridinium ring chemistry

Mashraqui, Sabir H.,Betkar, Rupesh,Chandiramani, Mukesh,Estarellas, Carolina,Frontera, Antonio

, p. 57 - 60 (2011)

A new chemodosimeter, Quino-P, recognizes the strongly nucleophilic cyanide by dual colorimetric and fluorescence 'off-on' signalling responses. Noteworthily, several other anions, even in significantly higher concentrations, induce no detectable photophysical perturbations. The chemodosimeter mechanism involves formation of a C4-cyano adduct, which exhibits an uncommon phenomenon of enhanced internal charge transfer interaction. The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2011.

Quinoline-4-carboxamide skeleton derivative and application thereof

-

Paragraph 0048-0051; 0095-0098, (2021/06/09)

The invention discloses a quinoline-4-formamide skeleton derivative and application thereof, belonging to the field of chemical medicines. The invention provides a compound as shown in a formula I or pharmaceutically acceptable salt thereof. The invention

Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity

Chen, Xiuli,Sun, Weining,Huang, Shenzhen,Zhang, Hailin,Lin, Guifeng,Li, Hui,Qiao, Jingxin,Li, Linli,Yang, Shengyong

, p. 10474 - 10495 (2020/11/02)

SIRT6 activation is thought to be a promising target for the treatment of many diseases, particularly cancer. Herein, we report the discovery of a series of new small-molecule SIRT6 activators. Structure-activity relationship analyses led to the identific

NEW ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS AND USES IN TREATMENTS OF OBESITY AND DIABETES MELLITUS - 087

-

Page/Page column 223, (2009/07/25)

The present invention relates to Acetyl Coenzyme A Carboxylase (ACC) inhibitors according to formula (I), or an enantiomer thereof, or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, E, L, Z and n are as defined herein, to processes for preparing such compounds, to pharmaceutical compositions containing them, to the use of such inhibitors and to methods for th eir therapeutic use, particularly in the treatments of obesity and diabetes mellitus.

Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues

Peng, Chi-Chi,Cape, Jonathan L.,Rushmore, Tom,Crouch, Gregory J.,Jones, Jeffrey P.

experimental part, p. 8000 - 8011 (2009/12/07)

CYP2C9 is a significant P450 protein responsible for drug metabolism. With the increased use of heterocyclic compounds in drug design, a rapid and efficient predrug screening of these potential type II binding compounds is essential to avoid adverse drug

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7482-91-9